Fisher & Paykel Healthcare Corporation Ltd banner

Fisher & Paykel Healthcare Corporation Ltd
OTC:FSPKF

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
OTC:FSPKF
Watchlist
Price: 22.52 USD
Market Cap: $13.4B

Wall St Price Targets

FSPKF Price Targets Summary
Fisher & Paykel Healthcare Corporation Ltd

Wall Street analysts forecast FSPKF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FSPKF is 25.28 USD with a low forecast of 22.02 USD and a high forecast of 29.89 USD.

Lowest Forecast
Price Target
22.02 USD
2% Downside
Average Forecast
Price Target
25.28 USD
12% Upside
Highest Forecast
Price Target
29.89 USD
33% Upside
Fisher & Paykel Healthcare Corporation Ltd Competitors:
Price Targets
PMVP
PMV Pharmaceuticals Inc
276% Upside

Revenue
Forecast

11% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 12%.

Gross Profit
Forecast

12% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
12% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 14%.

Operating Income
Forecast

14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 19%.

Pre-Tax Income
Forecast

14% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
14% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 20%.

Net Income
Forecast

15% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FSPKF's stock price target?
Price Target
25.28 USD

According to Wall Street analysts, the average 1-year price target for FSPKF is 25.28 USD with a low forecast of 22.02 USD and a high forecast of 29.89 USD.

What is the Revenue forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 12%.

What is the Gross Profit forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 14%.

What is the Operating Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 19%.

What is the Pre-Tax Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 20%.

What is the Net Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett